Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Pembrolizumab Melanoma

Sapna Patel

MD

🏢MD Anderson Cancer Center🌐USA

Associate Professor of Melanoma Medical Oncology

50
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Sapna Patel led SWOG S1801 demonstrating that neoadjuvant pembrolizumab followed by surgery and adjuvant pembrolizumab is superior to purely adjuvant pembrolizumab in resectable stage III-IV melanoma. Her work established the neoadjuvant-first paradigm in melanoma, reshaping treatment sequencing. She continues leadership in cooperative group melanoma trials.

Share:

🧪Research Fields 研究领域

SWOG S1801
neoadjuvant versus adjuvant pembrolizumab
resectable stage III-IV melanoma
event-free survival neoadjuvant benefit
SWOG melanoma committee

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Sapna Patel 的研究动态

Follow Sapna Patel's research updates

留下邮箱,当我们发布与 Sapna Patel(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment